文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Prevalence of high-grade cervical intraepithelial neoplasia in Mexican women aged under 40 years: a cross-sectional study.

作者信息

Pérez Esbeidy Guadalupe Jiménez, Limón-Toledo Laura Patricia, Carranza-Bustos Lizbeth Gabriela, González-Ojeda Alejandro, Cervantes-Guevara Gabino, Cervantes-Pérez Enrique, Ramírez-Ochoa Sol, Vázquez-Sánchez Sergio Jiram, González-Muñoz Samantha Emily, Meza Kathia Dayana Morfín, Guzmán-Díaz Jazmín Montserrat, Hernández-Ramirez Vianney Teresita, Cortés-Flores Ana Olivia, Álvarez-Villaseñor Andrea Socorro, Capetillo-Texson Carlos Enrique, Fuentes-Orozco Clotilde

机构信息

Department of Obstetrics and Gynaecology, High Specialty Medical Unit of the Centro Médico Nacional de Occidente del Instituto Mexicano del Seguro Social, Jalisco, Mexico.

Faculty of Medicine of the Universidad de Colima, Colima, Mexico.

出版信息

J Turk Ger Gynecol Assoc. 2025 Sep 3;26(3):167-173. doi: 10.4274/jtgga.galenos.2025.2025-5-2.


DOI:10.4274/jtgga.galenos.2025.2025-5-2
PMID:40899225
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12406961/
Abstract

OBJECTIVE: Cervical cancer is the second leading cause of cancer mortality among Mexican women aged 20-39 years, driven primarily by persistent human papillomavirus (HPV) infection. To determine the prevalence of high-grade squamous intraepithelial lesions (HSIL) in women under 40 years of age and identify associated risk factors. MATERIAL AND METHODS: An observational, cross-sectional study was conducted, including 359 women under 40 years old who were evaluated at the Gynecology and Obstetrics Medical Unit of Centro Médico Nacional de Occidente. Cervicovaginal cytology results indicative of HSIL were analyzed to determine prevalence and assess correlations with demographic and gynecological factors. RESULTS: The prevalence of HSIL was 39%, with the highest proportion of cases observed in women aged 35-39 years. The average age of sexual debut was 18.5 years, with an average of 2.93 sexual partners. Women diagnosed with HSIL were more likely to be older, married, and homemakers. HPV infection was highly prevalent across both low-grade squamous intraepithelial lesion and HSIL groups. CONCLUSION: A high prevalence of HPV infection was found, mostly in a relatively young population. A significant association between infection and risk factors, like marital status and gynecological/obstetric history, was also demonstrated. The findings also confirmed a relationship between HPV and HSIL.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb02/12406961/7606bdc06bec/JTurkGerGynecolAssoc-26-3-167-figure-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb02/12406961/7e3da7423b65/JTurkGerGynecolAssoc-26-3-167-figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb02/12406961/7606bdc06bec/JTurkGerGynecolAssoc-26-3-167-figure-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb02/12406961/7e3da7423b65/JTurkGerGynecolAssoc-26-3-167-figure-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eb02/12406961/7606bdc06bec/JTurkGerGynecolAssoc-26-3-167-figure-2.jpg

相似文献

[1]
Prevalence of high-grade cervical intraepithelial neoplasia in Mexican women aged under 40 years: a cross-sectional study.

J Turk Ger Gynecol Assoc. 2025-9-3

[2]
Diagnostic utility of cell block preparations from liquid-based cytology in cervical lesions: A comparative retrospective analysis.

Cytojournal. 2025-5-6

[3]
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

Cochrane Database Syst Rev. 2013-3-28

[4]
HPV testing alone as a test of cure after treatment with cervical loop excision: a retrospective register-based cohort study.

Infect Agent Cancer. 2025-8-27

[5]
The Utility of an Human Papillomavirus Genotype Assay for Cancer Screening in Self-Collected Urine and Vaginal Samples from Japanese Women.

Gynecol Obstet Invest. 2025

[6]
High-risk human papillomavirus diversity among indigenous women of western Botswana with normal cervical cytology and dysplasia.

BMC Infect Dis. 2024-10-15

[7]
Is age a determinant in cervical cancer screening in women aged 18 to 29?: An observational study.

Medicine (Baltimore). 2025-6-13

[8]
Medical and surgical interventions for the treatment of usual-type vulval intraepithelial neoplasia.

Cochrane Database Syst Rev. 2016-1-5

[9]
Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.

Lancet HIV. 2017-10-26

[10]
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

Cochrane Database Syst Rev. 2018-5-9

本文引用的文献

[1]
Prevalence of cervical intraepithelial lesions and associated factors among women attending a cervical cancer clinic in Western Uganda; results based on Pap smear cytology.

SAGE Open Med. 2024-5-16

[2]
Prevalence of High-Risk Human Papillomavirus Infection, Associated Risk Factors, and Relationship With Cervical Precancerous Lesions in Perimenopausal and Older Women in an Area With High Cervical Cancer Incidence in China.

Cureus. 2024-4-11

[3]
Clinical characteristics, HPV involvement, and demographic risk factors in women with cervical intraepithelial neoplasia complicated by vaginal intraepithelial neoplasia.

BMC Womens Health. 2024-4-4

[4]
Factors Associated With Precancerous Cervical Lesions in Human Immunodeficiency Virus-Infected Women: A Cross-Sectional Survey in Togo.

Clin Med Insights Oncol. 2024-3-19

[5]
Risk Profile of High-grade Cervical Lesions and Cervical Cancer Considering the Combination of Cytology, HPV Genotype, and Age among Women Undergoing Colposcopy.

Rev Bras Ginecol Obstet. 2023-11

[6]
Human papillomavirus associated cervical lesion: pathogenesis and therapeutic interventions.

MedComm (2020). 2023-9-14

[7]
Prevalence of human papillomavirus infection in abnormal pap smears.

Cytojournal. 2023-8-29

[8]
Abnormal Pap smear among pregnant women - Feasibility of opportunistic cervical screening.

Eur J Obstet Gynecol Reprod Biol X. 2023-7-20

[9]
Cervical Cancer Screening: A Review.

JAMA. 2023-8-8

[10]
Updates in Cervical Cancer Screening Guidelines, The Bethesda System for Reporting Cervical Cytology, and Clinical Management Recommendations.

J Clin Transl Pathol. 2023-6

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索